NewsRoom Articles - Page 98 of 606

FridaySep 22, 2023 4:20 am

420 with CNW — Brazilian Study Suggests Cannabis Helps Against Autism

With emerging research showing that cannabis holds promise for various health conditions, it comes as no surprise that some scientists have started conducting research on the drug’s usefulness in managing autism. Global researchers estimate that about 1% of the total population worldwide suffer from autism. However, few patients receive diagnoses, with many going about their daily lives undiagnosed. Now new research by a team of scientists in Brazil has made a new discovery concerning the use of cannabis extracts in managing autism. This isn’t the first study to evaluate this link, as a number of separate studies have also noted…

ThursdaySep 21, 2023 4:20 pm

420 with CNW — Minnesota Supreme Court Says Cannabis Smell Insufficient Justification for Searching Vehicles

The Minnesota Supreme Court has established that the mere presence of a cannabis scent does not, by itself, provide sufficient grounds for law enforcement officers to conduct a vehicle search. The ruling stemmed from an incident that occurred during a traffic stop in Meeker County in 2021 when Adam Torgerson found himself being pulled over by Litchfield police for excessive auxiliary lights on his car’s grill. During the stop, one of the officers claimed that they could detect the scent of marijuana emanating from the open car window. Torgerson, accompanied by his wife and a child, vehemently denied the presence…

ThursdaySep 21, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) to Demonstrate DehydraTECH-CBD Benefits in Upcoming Investigational New Drug Application Submission

Lexaria’s IND application builds on five previous human clinical studies showing zero serious adverse effects and evidencing a reduction in resting blood pressure in test subjects DehydraTECH(TM)-CBD has the potential to have pronounced clinical benefits relative to the available anti-hypertensive therapeutics on the market today Work mostly under Lexaria’s control was completed earlier this year, including the batch manufacturing of DehydraTECH-CBD and placebo materials necessary for the IND application Lexaria is waiting to submit until the necessary documentation outside of their control is ready for the IND application Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains…

ThursdaySep 21, 2023 4:20 am

420 with CNW — California Lawmakers Send Cannabis Cafe Bill to Governor for Enactment

The California Assembly has approved a bill to legalize marijuana cafes in the state; the body sent the bill to Governor Gavin Newsom’s desk for his signature. Bill AB 374 would allow recreational cannabis dispensaries to provide customers with noncannabis drinks and foods as long as they receive approval from local authorities. Senate lawmakers received the measure from assemblymembers, made slight amendments, and approved it in a 33 to 3 vote nearly one week ago before sending it back to the assembly for a concurrence vote. The assembly voted in favor of the amended cannabis cafe bill just a few…

WednesdaySep 20, 2023 4:20 pm

420 with CNW — Twist of Fate? DEA Now Tasked with Steering Marijuana Rescheduling

The United States is on the brink of a groundbreaking shift in its approach to marijuana policy. However, a significant obstacle stands in the way of this reform: the Drug Enforcement Administration (DEA). Recognizing marijuana’s medical value, the U.S. Department of Health and Human Services ( HHS) recommended reclassifying marijuana as a Schedule III controlled substance in response to President Joe Biden's call for a comprehensive review of marijuana scheduling last year. This pivotal moment in federal government policy places the key marijuana decision in the hands of the DEA, an agency historically associated with the country's war on drugs.…

WednesdaySep 20, 2023 4:20 am

420 with CNW — Marijuana ETFs See Green as Hopes for Federal Marijuana-Policy Reform Rise

Cannabis Exchange-Traded Funds (ETFs) surged in value in September as positive federal action renewed investor interest in the cannabis industry. Shortly after the U.S. Department of Health and Human Services recommended that the Drug Enforcement Administration (DEA) reclassify cannabis to Schedule III from Schedule I and ease federal marijuana restrictions, marijuana-related ETFs began to soar as investors started investing in the cannabis industry. America’s state-legal cannabis sector is the fastest-growing sector in the nation, generating billions of dollars in yearly revenue. However, the industry has been consistently handicapped by federal regulation. Federal law still classifies cannabis as a Schedule I…

TuesdaySep 19, 2023 4:20 pm

420 with CNW — Caribbean, Latam Nations Agree War on Drugs Has Failed, New Solutions Needed

A coalition of 19 Caribbean and Latin American nations has jointly released a statement, underscoring the imperative need for a reevaluation of global drug policies. In a conference held over the weekend, these countries expressed their dissatisfaction with the current punitive strategy for combating the global drug issue, noting that it has failed to yield the desired results and has often exacerbated underlying problems while exploiting the vulnerabilities of their societies and territories. The statement received support from representatives of numerous nations, including Brazil, Uruguay, Nicaragua, Colombia, Guatemala, El Salvador, Panama, Venezuela, Chile, Bolivia, Cuba, Honduras, Ecuador, Costa Rica, Peru,…

TuesdaySep 19, 2023 4:20 am

420 with CNW — Cannabis Rescheduling Recommendation Far Below Biden’s Campaign Promises, Advocates Say

Nearly two years after President Joe Biden took office, policy experts and drug-reform advocates aren’t happy with the Biden administration’s efforts to fulfill the campaign’s cannabis promises. Last month, the Biden administration recommended that the U.S. Drug Enforcement Administration (DEA) reclassify marijuana and asked federal drug officials to consider removing the decades-long restrictions on marijuana. The Department of Health and Human Services (HHS) issued the cannabis rescheduling recommendation to the DEA after President Biden sent a request to the HHS calling for a review of the rescheduling of marijuana as a Schedule I drug with no medical application. Schedule III…

MondaySep 18, 2023 4:20 pm

420 with CNW — Study Shows Users of Medical Cannabis Register Improvements in Depression, Anxiety and Pain

A recent study in the "PLoS ONE" journal found that more than 2,300 individuals with persistent health issues experienced improved well-being and reduced fatigue within the first three months of using medicinal cannabis. The study was centered on the responses obtained from eligible Australian patients who participated in the QUEST Initiative. The participants' age spectrum spanned from 18 to 97 years of age, with an average age of 51. Among the participants, 62.8% were women while 37.2% were men. The majority of participants reported experiencing chronic pain (69%), followed by insomnia (23%), anxiety (22%), and a combination of anxiety and…

MondaySep 18, 2023 10:30 am

420 Expo 2023: Celebrating the Cannabis Culture

Cannabis enthusiasts, investors, decision-makers, and business owners, are invited to attend the 420 Expo 2023 to be held in New Jersey Expo Center, Edison, NJ from September 29 – October 1, 2023. The electrifying event is set to blaze the ever-evolving cannabis landscape, including medical experts discussing the therapeutic potential of cannabis and professionals sharing their success stories. 420 Expo 2023 is a one-of-a-kind gathering that celebrates the world of cannabis culture, from its insightful medical applications to its important role in mainstream culture. Featuring the legendary Cheech Marin as a special guest host, the dynamic cannabis convergence promises to…

News and publishing service for cannabis related companies

Contact us: 512.354.7000